Fresno, CA – September 15, 2017 – Tamarack Biotics announced the results from two clinical trials, which tested TruActive’s ability to stimulate elderly immune systems and to reduce asthma symptoms in a mouse-model experiment. TruActive is the world’s first dairy product to gain regulatory approval for an alternative to pasteurization.
Immune systems weaken with age, and until now, there has been no known way to stimulate and strengthen them. This condition is known as Immunosenescence. In cooperation with UC Davis, Tamarack completed a double-blind, placebo-controlled Tetanus vaccine response clinical trial on 35 adults over 60 years of age. Twice a day for 4 weeks, the subjects consumed 7.5 grams of TruActive or a soy protein comparator and then were administered a Tetanus vaccine. After four more weeks of consumption, blood tests confirmed the level of antibodies produced by each subject. The subjects who consumed TruActive MPC 85 averaged a 12.7-fold Tetanus antibody increase, while the subjects who consumed the soy protein only experienced a 5.8-fold increase. A similar trial conducted by UC Davis in 2010 showed only a slightly statistically significant increase in whey protein consumption compared to the same soy protein.
Bob Comstock, Tamarack Biotics’ CEO stated “The Immunosenescence clinical trial proves that TruActive MPC 85 invigorates elderly immune systems and should help keep people well. The health benefits provided by a more than doubling in vaccine response are astounding. We, and our research partners at UC Davis, were pleasantly surprised by this result and we look forward to developing retail products with our partners. ”
Additionally, a study in Switzerland investigated TruActive’s ability to reduce asthma symptoms in a mouse model experiment. Six mice in each group were fed increasing levels of UHT milk, raw milk or TruActive MPC 85 for 6 weeks. During the final two weeks, the mice were exposed to house dust mite extract 3 times per week. Asthma symptom severity was measured by airway Eosinophil concentration and the study proved TruActive MPC 85 reduced Eosinophil concentration by 20% compared to UHT milk. Mr. Comstock clarified, “Asthma represents an enormous and growing problem globally. Multiple studies demonstrate that raw milk consumption, particularly early in life, reduces the number of people who develop allergies, including asthma. The scientific community believes immune active proteins provide this protective effect. The Swiss study highlights TruActive’s ability to deliver immune active proteins in a safe and effective product, which should not only protect children from developing allergies but also provide a therapeutic effect that reduces asthma symptoms.”